Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mette Haugli"'
Autor:
Tøri Vigeland Lerum, Niklas Nyboe Maltzahn, Pål Aukrust, Marius Trøseid, Katerina Nezvalova Henriksen, Trine Kåsine, Anne-Ma Dyrhol-Riise, Birgitte Stiksrud, Mette Haugli, Bjørn Blomberg, Bård Reiakvam Kittang, Asgeir Johannessen, Raisa Hannula, Saad Aballi, Anders Benjamin Kildal, Ragnhild Eiken, Tuva Børresdatter Dahl, Fridtjof Lund-Johansen, Fredrik Müller, Jezabel Rivero Rodriguez, Carin Meltzer, Gunnar Einvik, Thor Ueland, Inge Christoffer Olsen, NOR-SOLIDARITY Consortium, Andreas Barratt-Due, Trond Mogens Aaløkken, Ole Henning Skjønsberg
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract The association between pulmonary sequelae and markers of disease severity, as well as pro-fibrotic mediators, were studied in 108 patients 3 months after hospital admission for COVID-19. The COPD assessment test (CAT-score), spirometry, dif
Externí odkaz:
https://doaj.org/article/88393d531e5a4b23b4265b267e8189ee
Autor:
Andreas Barratt-Due, Asgeir Johannessen, Lars Thoresen, Pål Aukrust, Bente Halvorsen, Birgitte Stiksrud, Katerina Nezvalova Henriksen, Beate Vestad, Trine Kåsine, Reidar Kvåle, Anders Benjamin Kildal, Roy Bjørkholt Olsen, Johannes R. Hov, Tori Vigeland Lerum, Marius Trøseid, Thor Ueland, Trine Ranheim, Mette Haugli, Tove Lekva, Åse Berg, Annika E. Michelsen, Hilde Skudal, Ragnhild Eiken, Ravinea Manotheepan, Anne Ma Dyrhol-Riise, Carl Magnus Ystrøm, Inge C. Olsen, Hedda Hoel, Anders Tveita, Kristian Tonby, Kristian Holm, Tuva B. Dahl, Raisa Hannula, Bård Reiakvam Kittang, Ole Henning Skjønsberg, Saad Aballi, Nina Vibeche Skei
ObjectiveAlthough COVID-19 is primarily a respiratory infection, mounting evidence suggests that the GI tract is involved in the disease, with gut barrier dysfunction and gut microbiota alterations being related to disease severity. Whether these alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::392ae3b6b3abd158d7cf543ac73f5249
https://doi.org/10.1101/2021.07.13.21260412
https://doi.org/10.1101/2021.07.13.21260412
Autor:
Anders Benjamin Kildal, Saad Aballi, Carin Meltzer, Trond Mogens Aaløkken, Fridtjof Lund-Johansen, Katerina Nezvalova Henriksen, Mette Haugli, Anne-Ma Dyrhol-Riise, Ragnhild Eiken, Trine Kåsine, Inge C. Olsen, Birgitte Stiksrud, Niklas Nyboe Maltzahn, Fredrik Müller, Gunnar Einvik, Tori Vigeland Lerum, Ole Henning Skjønsberg, Asgeir Johannessen, Jezabel Rivero Rodriguez, Pål Aukrust, Thor Ueland, Marius Trøseid, Bjørn Blomberg, Andreas Barratt-Due, Bård Reiakvam Kittang, Tuva B. Dahl, Raisa Hannula
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
The association between pulmonary sequelae and markers of disease severity, as well as pro-fibrotic mediators, were studied in 108 patients 3 months after hospital admission for COVID-19. The COPD assessment test (CAT-score), spirometry, diffusion ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b96c06ec86aa1ecc732874817d796c4
http://hdl.handle.net/10852/90608
http://hdl.handle.net/10852/90608
Autor:
Tuva B. Dahl, Hilde Skudal, Ane-Kristine Finbråten, Skåra Kh, Le Lak, Kristian Tonby, Cathrine Fladeby, Bård Reiakvam Kittang, Raisa Hannula, Andreas Barratt-Due, Fridtjof Lund-Johansen, Alexander Mathiessen, Anne Margarita Dyrhol-Riise, Bjørn Blomberg, Asgeir Johannessen, Carl Magnus Ystrøm, Lars Thoresen, Katerina Nezvalova Henriksen, Hedda Hoel, Mette Haugli, Pawel Mielnik, Saad Aballi, Hoff Dal, Gernot Ernst, Birgitte Tholin, Åse Berg, Marius Trøseid, Ragnhild Eiken, Susanne Gjeruldsen Dudman, Jan Terje Andersen, Olav Dalgard, Trine Kåsine, Lars Heggelund, Steffensen A, Müller F, Anders Benjamin Kildal, Skei Nv, Roy Bjørkholt Olsen, P. Aukrust, Inge C. Olsen, Tran T, Aleksander Rygh Holten, Anders Aune Tveita
Publikováno v:
SSRN Electronic Journal.
Background: There is an urgent need for new treatment modalities in COVID-19 patients. Recently, the WHO Solidarity trial showed no effects of remdesivir or hydroxychloroquine (HCQ) on mortality. However, the antiviral effects of these drugs and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::494720c36df68241feda04a9e18f0df5
https://doi.org/10.2139/ssrn.3774182
https://doi.org/10.2139/ssrn.3774182
Autor:
Asgeir Johannessen, Hedda Hoel, Roy Bjørkholt Olsen, Karoline Hansen Skåra, Aleksander Rygh Holten, Anne Ma Dyrhol-Riise, Anders Benjamin Kildal, Carl Magnus Ystrøm, Fridtjof Lund-Johansen, Alexander Mathiessen, Trine Kåsine, Susanne Gjeruldsen Dudman, Cathrine Fladeby, Nina Vibeche Skei, Birgitte Tholin, Åse Berg, Trung Tran, Gernot Ernst, Anne Steffensen, Saad Aballi, Ane-Kristine Finbråten, Inge C. Olsen, Pål Aukrust, Olav Dalgard, Jan Terje Andersen, Bård Reiakvam Kittang, Lars Heggelund, Anders Tveita, Bjørn Blomberg, Marius Trøseid, Tuva B. Dahl, Mette Haugli, Kristian Tonby, Ragnhild Eiken, Lan Ai Kieu Le, Raisa Hannula, Fredrik Müller, Dag Arne Lihaug Hoff, Lars Thoresen, Hilde Skudal, Andreas Barratt-Due, Pawel Mielnik, Katerina Nezvalova-Henriksen
Publikováno v:
Annals of internal medicine
Annals of Internal Medicine
Annals of Internal Medicine
BACKGROUND: New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91e4ff4f7aa55e6059e761e5580bc313